Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

INFECTION

Routine screening for hepatitis C in MSM on HIV PrEP

Reassurance provided by pre-exposure prophylaxis (PrEP) for HIV might lead to increased sexual risk-taking in men who have sex with men (MSM), potentially increasing the risk of transmitting other infections. A recent study has shown increased transmission of hepatitis C virus (HCV) in this population, suggesting a need for HCV screening.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: A proposed management algorithm for MSM using PrEP.

References

  1. Sewell, J. et al. Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics. Int. J. Drug Policy 43, 33–43 (2017).

    Article  Google Scholar 

  2. Eaton, L. A. et al. Serosorting sexual partners and risk for HIV among men who have sex with men. Am. J. Prev. Med. 33, 479–485 (2007).

    Article  Google Scholar 

  3. Bavinton, B. R. et al. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV 5, e438–e447 (2018).

    Article  Google Scholar 

  4. Cohen, M. S. et al. Prevention of HIV-1 infection with early antiretroviral therapy. N. Engl. J. Med. 365, 493–505 (2011).

    Article  CAS  Google Scholar 

  5. Marcus, J. L. et al. Redefining human immunodeficiency virus (HIV) preexposure prophylaxis failures. Clin. Infect. Dis. 65, 1768–1769 (2017).

    Article  Google Scholar 

  6. Grant, R. M. et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N. Engl. J. Med. 363, 2587–2599 (2010).

    Article  CAS  Google Scholar 

  7. US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States — 2017 update: a clinical practice guideline. Centers for Disease Control and Prevention https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf (2018).

  8. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. NIH https://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf (2019).

  9. Price, J. C. et al. Sexually acquired hepatitis C infection in HIV-uninfected men who have sex with men using preexposure prophylaxis against HIV. J. Infect. Dis. https://doi.org/10.1093/infdis/jiy670 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Centers for Disease Control and Prevention. Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men — New York City, 2005–2010. MMWR Morb. Mortal. Wkly Rep. 60, 945–950 (2011).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Douglas S. Krakower.

Ethics declarations

Competing interests

D.S.K. has been a consultant to Fenway Health for a study funded by Gilead Sciences and has received compensation for developing and/or delivering medical education related to PrEP for Medscape, MED-IQ and UptoDate, Inc. K.H.M. has conducted research with unrestricted project support from Gilead Sciences, Merck and ViiV Healthcare and has received compensation for developing medical education related to PrEP for UptoDate, Inc.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krakower, D.S., Mayer, K.H. Routine screening for hepatitis C in MSM on HIV PrEP. Nat Rev Urol 16, 272–274 (2019). https://doi.org/10.1038/s41585-019-0163-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41585-019-0163-9

This article is cited by

Search

Quick links

Nature Briefing Microbiology

Sign up for the Nature Briefing: Microbiology newsletter — what matters in microbiology research, free to your inbox weekly.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing: Microbiology